ARCHIVES

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

This article is from The Cancer Letter archive.

Vol. 14 No. 23 | June 3, 1988

Download PDF Visit The Full Archive

Related Articles

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

House Science Committee Chairman Questions NIH Budget Increases.

February 2, 2001

Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal

June 18, 1982

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

Three Bomb Threats At NIH In One Week result In Evacuations, Investigations

August 2, 1996